Cargando…

Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination

COVID-19 mRNA vaccines effectively reduce incidence of severe disease, hospitalisation and death. The biodistribution and pharmacokinetics of the mRNA-containing lipid nanoparticles (LNPs) in these vaccines are unknown in humans. In this study, we used qPCR to track circulating mRNA in blood at diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Fertig, Tudor Emanuel, Chitoiu, Leona, Marta, Daciana Silvia, Ionescu, Victor-Stefan, Cismasiu, Valeriu Bogdan, Radu, Eugen, Angheluta, Giulia, Dobre, Maria, Serbanescu, Ana, Hinescu, Mihail Eugen, Gherghiceanu, Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313234/
https://www.ncbi.nlm.nih.gov/pubmed/35884842
http://dx.doi.org/10.3390/biomedicines10071538
Descripción
Sumario:COVID-19 mRNA vaccines effectively reduce incidence of severe disease, hospitalisation and death. The biodistribution and pharmacokinetics of the mRNA-containing lipid nanoparticles (LNPs) in these vaccines are unknown in humans. In this study, we used qPCR to track circulating mRNA in blood at different time-points after BNT162b2 vaccination in a small cohort of healthy individuals. We found that vaccine-associated synthetic mRNA persists in systemic circulation for at least 2 weeks. Furthermore, we used transmission electron microscopy (TEM) to investigate SARS-CoV-2 spike protein expression in human leukemic cells and in primary mononuclear blood cells treated in vitro with the BNT162b2 vaccine. TEM revealed morphological changes suggestive of LNP uptake, but only a small fraction of K562 leukemic cells presented spike-like structures at the cell surface, suggesting reduced levels of expression for these specific phenotypes.